Characterization of microRNA-29 family expression and investigation of their mechanistic roles in gastric cancer

Carcinogenesis

Volumn 35, Issue 2, 2014, Pages 497-506

  Gong, Jianan ^a   Li, Jianxiong ^b   Wang, Yi ^c   Liu, Changzheng ^a   Jia, Hongyan ^d   Jiang, Chongliang ^e   Wang, Yuxuan ^f   Luo, Min ^a   Zhao, Hongmei ^a   Dong, Lei ^a   Song, Wei ^a   Wang, Fang ^a   Wang, Weibin ^g   Zhang, Junwu ^a   Yu, Jia ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c CANCER HOSPITAL   (China)

^d SHANXI MEDICAL UNIVERSITY   (China)

^e ChongQing Police Security Bureau Nanan Zone   (China)

^f SHANXI CANCER HOSPITAL   (China)

^g PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN D2; GELATINASE A; MICRORNA 29; MICRORNA 29A; MICRORNA 29B; MICRORNA 29C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER PROGNOSIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; STOMACH CANCER; TUMOR VOLUME; XENOGRAFT;

ANIMALS; APOPTOSIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN D2; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; MATRIX METALLOPROTEINASE 2; MICE; MICE, NUDE; MICRORNAS; NEOPLASM INVASIVENESS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 84893398343     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt337     Document Type: Article

References (36)

1. Zabaleta,J. (2012) Multifactorial etiology of gastric cancer. Methods Mol. Biol., 863, 411-435.
2. Jemal,A. et al. (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol. Biomarkers Prev., 19, 1893-1907.
3. Mendell,J.T. et al. (2012) MicroRNAs in stress signaling and human disease. Cell, 148, 1172-1187.
4. Gill,R.S. et al. (2011) Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival, mortality, and morbidity. J. Surg. Oncol., 104, 692-698.
5. Wu,W.K. et al. (2010) MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene, 29, 5761-5771.
6. Ventura,A. et al. (2009) MicroRNAs and cancer: short RNAs go a long way. Cell, 136, 586-591.
7. Hui,A. et al. (2011) Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies. BMC Cancer, 11, 500.
8. Schmitt,M.J. et al. (2013) miRNA-29: a microRNA family with tumor-suppressing and immune-modulating properties. Curr. Mol. Med, 13, 572-585.
9. Nguyen,T. et al. (2011) Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma. Epigenetics, 6, 388-394.
10. Park,S.Y. et al. (2009) miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat. Struct. Mol. Biol., 16, 23-29.
11. Cui,Y. et al. (2011) MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer. PLoS One, 6, e25872.
12. Yu,J. et al. (2006) Human microRNA clusters: genomic organization and expression profile in leukemia cell lines. Biochem. Biophys. Res. Commun., 349, 59-68.
13. Yu,J. et al. (2008) MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia. Proc. Natl Acad. Sci. USA, 105, 19300-19305.
14. Wang,F. et al. (2011) Regulation of erythroid differentiation by miR-376a and its targets. Cell Res., 21, 1196-1209.
15. Li,L. et al. (2012) Downregulation of microRNAs miR-1, -206 and -29 stabilizes PAX3 and CCND2 expression in rhabdomyosarcoma. Lab. Invest., 92, 571-583.
16. Fang,J.H. et al. (2011) MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression. Hepatology, 54, 1729-1740.
17. Ogawa,T. et al. (2003) Synergistic effects of activin and FSH on hyperphosphorylation of Rb and G1/S transition in rat primary granulosa cells. Mol. Cell. Endocrinol., 210, 31-38.
18. Sicinski,P. et al. (1996) Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature, 384, 470-474.
19. Gómez Lahoz,E. et al. (1999) Cyclin D- and E-dependent kinases and the p57(KIP2) inhibitor: cooperative interactions in vivo. Mol. Cell. Biol., 19, 353-363.
20. Wang,F. et al. (2012) miR-29a and miR-142-3p downregulation and diagnostic implication in human acute myeloid leukemia. Mol. Biol. Rep., 39, 2713-2722.
21. Wang,X.S. et al. (2012) MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia. Blood, 119, 4992-5004.
22. Broderick,J.A. et al. (2011) MicroRNA therapeutics. Gene Ther., 18, 1104-1110.
23. Soifer,H.S. et al. (2007) MicroRNAs in disease and potential therapeutic applications. Mol. Ther., 15, 2070-2079.
24. Schotte,D. et al. (2012) MicroRNAs in acute leukemia: from biological players to clinical contributors. Leukemia, 26, 1-12.
25. Santanam,U. et al. (2010) Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression. Proc. Natl Acad. Sci. USA, 107, 12210-12215.
26. Fabbri,M. et al. (2007) MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl Acad. Sci. USA, 104, 15805-15810.
27. Gebeshuber,C.A. et al. (2009) miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep., 10, 400-405.
28. Sengupta,S. et al. (2008) MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc. Natl Acad. Sci. USA, 105, 5874-5878.
29. Pekarsky,Y. et al. (2010) Is miR-29 an oncogene or tumor suppressor in CLL? Oncotarget, 1, 224-227.
30. Stamatopoulos,B. et al. (2009) microRNA-29c and microRNA-223 downregulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. Blood, 113, 5237-5245.
31. Ding,D.P. et al. (2011) miR-29c induces cell cycle arrest in esophageal squamous cell carcinoma by modulating cyclin E expression. Carcinogenesis, 32, 1025-1032.
32. Chiles,T.C. (2004) Regulation and function of cyclin D2 in B lymphocyte subsets. J. Immunol., 173, 2901-2907.
33. Blain,S.W. (2008) Switching cyclin D-Cdk4 kinase activity on and off. Cell Cycle, 7, 892-898.
34. Kehn,K. et al. (2004) The role of cyclin D2 and p21/waf1 in human T-cell leukemia virus type 1 infected cells. Retrovirology, 1, 6.
35. Sampieri,C.L. et al. (2010) Expression of matrix metalloproteinases 2 and 9 in human gastric cancer and superficial gastritis. World J. Gastroenterol., 16, 1500-1505.
36. Eisen,M.B. et al. (1998) Cluster analysis and display of genome-wide expression patterns. Proc. Natl Acad. Sci. USA, 95, 14863-14868.